Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer (ABC) patients (pts): focus on luminal cancers. Results from GIM13 - AMBRA study

G. Mustacchi, M. Cazzaniga, M. Giordano, O. Garrone, M. Donadio, L. Del Mastro, L. Livi, C. Natoli, A. Michelotti, A. Turletti, F. Riccardi, P. Marchetti, F. Montemurro, E. Romagnoli, S. De Placido, L. Biganzoli, G. Bisagni, E. Bria

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)vi34
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - Oct 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this